tirzepatide cardiovascular outcomes trial results july 2025 compared with semaglutide and 10-year disease risk reduction How the weight loss drug

However, if nausea, vomiting, or other effects remain severe after two months at a given dose, you may not tolerate semaglutide well

hCAECs, human coronary artery endothelial cells

Metabolic syndrome is considered as a diagnostic entity

Your provider will monitor your progress and help determine the most appropriate plan for you

Although Qsymia (phentermine + topiramate) is FDA approved for weight loss, taking just topiramate off label still has significant benefits and, having a generic option, is much more affordable, making it a strong candidate for both weight loss and as a maintenance drug to help keep the weight off after a GLP1 regimen